Clinical Trials Browser

Phase 2 × Amyloidosis × ixazomib × Clear all

NCT02924272 2025-03-12

Ixazomib Rollover Study

Phase 2 Completed

32 enrolled 13 charts

LymphoidPlasma cell

Amyloidosis, Lymphoma, Multiple Myeloma